Skip to main content
International Journal of Epidemiology logoLink to International Journal of Epidemiology
. 2021 Jan 11;50(3):931–941. doi: 10.1093/ije/dyaa273

The combined impact of smoking, obesity and alcohol on life-expectancy trends in Europe

Fanny Janssen 1,2,, Sergi Trias-Llimós 3,4, Anton E Kunst 5
PMCID: PMC8271206  PMID: 33432332

Abstract

Background

Smoking, obesity and alcohol abuse greatly affect mortality and exhibit a distinct time dynamic, with their prevalence and associated mortality rates increasing and (eventually) declining over time. Their combined impact on secular trends in life expectancy is unknown but is relevant for understanding these trends. We therefore estimate the combined impact of smoking, obesity and alcohol on life-expectancy trends in Europe.

Methods

We used estimated national age-specific smoking-, obesity- and alcohol-attributable mortality fractions for 30 European countries by sex, 1990–2014, which we aggregated multiplicatively to obtain lifestyle-attributable mortality. We estimated potential gains in life expectancy by eliminating lifestyle-attributable mortality and compared past trends in life expectancy at birth (e0) with and without lifestyle-attributable mortality. We examined all countries combined, by region and individually.

Results

Among men, the combined impact of smoking, obesity and alcohol on e0 declined from 6.6 years in 1990 to 5.8 years in 2014, mainly due to declining smoking-attributable mortality. Among women, the combined impact increased from 1.9 to 2.3 years due to mortality increases in all three lifestyle-related factors. The observed increase in e0 over the 1990–2014 period was 5.0 years for men and 4.0 years for women. After excluding lifestyle-attributable mortality, this increase would have been 4.2–4.3 years for both men and women.

Conclusion

Without the combined impact of smoking, obesity and alcohol, the increase over time in life expectancy at birth would have been smaller among men but larger among women, resulting in a stable increase in e0, parallel for men and women.

Keywords: Health behaviour, lifestyle, Europe, life expectancy, mortality, time trends


Key Messages

  • We observed a large combined impact of smoking, obesity, and alcohol on trends in life expectancy at birth (e0) in Europe. Without its impact, the increase over time in e0 would have been smaller among men but larger among women.

  • We identified a stable increase in life expectancy for non-lifestyle-attributable mortality, which occurred in parallel for men and women in most European countries, and was, for men, more similar between countries than for the observed life-expectancy trends.

  • Distinguishing between non-lifestyle-attributable mortality and lifestyle-attributable mortality is important to better understand current trends in life expectancy and to predict future trends.

Introduction

Smoking, alcohol abuse and behavioural factors resulting in overweight and obesity (unhealthy diets and insufficient physical activity) are important contributors to non-communicable-disease mortality.1 Smoking, alcohol and obesity are considered to be three key preventable risk factors and public-health problems in Europe,2,3 with a high impact on mortality and life expectancy.4–14 However, the contributions of smoking, obesity and alcohol are not constant over time, because these lifestyle factors tend to evolve as wave-shaped lifestyle ‘epidemics’ characterized by an initial unprecedented increase followed (eventually) by a decline.15–20 Given important (recent) stagnations in increases in life expectancy in Europe over time,21–25 it is important to assess how these lifestyle factors influenced secular trends in life expectancy in different European countries.

Previous research clearly revealed the time-varying nature of smoking-, obesity- and alcohol-attributable mortality. Past trends in smoking-attributable mortality show a clear wave pattern of increases followed by declines that occurred approximately 30–40 years later than a similar wave pattern for smoking prevalence.15 This wave pattern has been observed among men in all European countries, whereas smoking-attributable mortality appears to still be increasing among women in the majority of European countries.16 The tripling of obesity prevalence in Europe since 198026 has resulted in clear increases in obesity-attributable mortality fractions over the 1975–2016 period,27 albeit with a recent slowing-down of the rates of increase.28 Alcohol prevalence and, subsequently, alcohol-attributable mortality levels, which are especially high among Eastern-European men,29,30 had been mostly increasing in Eastern and North-western Europe, although recently they have been stagnating or declining in most of these countries. In most South-western-European countries, these levels have been steadily declining, albeit more slowly in recent years.19,20

Also, various Global Burden of Disease studies estimated trends in risk-attributable deaths and Disability Adjusted Life Years for different (groups of) risks (behavioural, environmental, occupational, metabolic) from 1990 onwards.31–34 We will complement this work by estimating the effects of lifestyle-attributable mortality on secular trends in life expectancy.

Previous studies on the impact of smoking-, obesity- and alcohol-attributable mortality on trends in life expectancy mostly examined the impact for a single lifestyle factor and usually for only a selection of countries.22,23,27,30,35–37 They found that smoking played an important role in the stagnation of life-expectancy increases among men in many North-western European countries in the 1950s and 1960s, and in other European countries and among women in more recent decades.22,23,35 For obesity, an increasingly large effect on life-expectancy levels over recent decades was observed.27 A similar trend was found for alcohol in Finland.36 In addition, the dissimilar trends in alcohol prevalence between Eastern and non-Eastern Europe have greatly contributed to diverging (1990–2005) and converging (2005 onwards) life-expectancy levels across Europe.30 Although these previous results suggest that the combined effect of smoking, obesity and alcohol on life-expectancy trends could be large, this combined effect has not yet been studied.

Our objective is, therefore, to estimate, for the first time, the combined impact of smoking, obesity (BMI ≥ 30 kg/m2) and alcohol abuse on trends in life expectancy for men and women in Europe and to determine how trends in life expectancy would look like without this combined impact. We study the majority of European countries (N = 30) combined, with additional attention on differences by region (North, West, South, Central, East) and country.

Data and methods

For the 30 countries under study, we used previously calculated estimates of smoking-, obesity- and alcohol-attributable mortality fractions by sex and single adult ages (smoking: 35–100 years; obesity and alcohol: 20–100 years) (see next paragraph).16,20,38 In addition, we used age-, sex-, country- and year-specific all-cause mortality and population data from the Human Mortality Database.39 We studied the period 1990–2014 because alcohol-attributable mortality could be estimated only since 1990 and smoking-attributable mortality could not be estimated after 2014 for several countries due to the unavailability of lung-cancer-mortality rates for more recent years (see Supplementary Data & Methods—Appendix 1, available as Supplementary data at IJE online, for the data availability by country for the different elements).

Smoking-attributable-mortality fractions were indirectly estimated using a simplified version of the commonly applied Peto-Lopez methodology.16,40,41 The method estimates exposure to smoking based on lung-cancer mortality rates that are adjusted for the part not due to smoking and applies to this exposure the relative risks (RRs) of dying from smoking. For obesity-attributable mortality, the estimates stem from the application of the population-attributable fraction formula to (estimated) prevalence data42 using all-cause RRs of dying from obesity,43 in line with previous studies, e.g.27. Alcohol-attributable mortality fractions were estimated based on alcohol-attributable mortality rates obtained from the Global Burden of Disease 2017 study,31,44 adjusted for ages 65+ using the age pattern for alcohol-related causes of death.20

To estimate the share of mortality due to smoking, obesity and alcohol combined, we used the multiplicative aggregation of the fractions for the individual risk factors, using the formula45:

LAMF= PAF1..n=1- i=1n(1-PAFi)

where i stands for the individual risk factor and PAF1.n stands for the lifestyle-attributable mortality fraction for the three lifestyle factors combined, which we refer to as the lifestyle-attributable mortality fraction (LAMF). This aggregation rests on the strong assumption that risk factors are independent and uncorrelated.45 However, validation studies have demonstrated that the resulting estimates may closely resemble the true combined effect.31,46

By multiplying the age- and sex-specific smoking-, obesity-, alcohol- and lifestyle-attributable mortality fractions to the respective all-cause mortality rates, we obtained age- and sex-specific smoking-, obesity-, alcohol- and lifestyle-attributable mortality rates. By multiplying the all-cause mortality rates by one minus the fractions, we obtained the age- and sex-specific non-smoking-, non-obesity-, non-alcohol- and non-lifestyle-attributable mortality rates.

To aid the interpretation of the results from our main analysis (see below), we performed two initial analyses. First, we examined the trends over time in the share of mortality that is attributable to the different lifestyle factors. We obtained shares across adult ages (20–100 years) by applying direct standardization to the age-specific fractions using the age composition of deaths for the specific populations in 2010. Second, we examined the impact on life expectancy at birth (e0) of the separate and combined lifestyle factors, and the trends therein over time, by calculating the potential gain in life expectancy (PGLE)47 if smoking-, obesity-, alcohol- and lifestyle-attributable mortality were eliminated. The PGLE values are calculated by comparing the e0 value for all-cause mortality to the e0 value based on life-table calculations applied to non-smoking-, non-obesity-, non-alcohol- and non-lifestyle-attributable mortality rates, respectively.

For our main aim of estimating the (combined) impact of smoking, obesity and alcohol on life-expectancy trends in Europe, we graphically compared the trends over time in observed e0 (= for all-cause mortality) with the trends in estimated e0 values (= for non-smoking-, non-obesity-, non-alcohol- and non-lifestyle-attributable mortality) (see before). To compare the overall change in observed e0 over the 1990–2014 period with this change in estimated e0 values, we subtracted the respective e0 values in 1990 from the respective e0 values in 2014.

See the Supplementary Data & Methods document, available as Supplementary data at IJE online, for more details.

Results

Before describing the results of our main analysis in Table 2 and Figure 3, we first describe the results of our background analyses in Figure 1, Table 1 and Figure 2. Whereas the tables and figures in the manuscript show the results by European region, the respective supplementary tables and figures, available as Supplementary data at IJE online, show the country-specific results.

Table 2.

Impact of smoking, obesity and alcohol (separately and combined) on the change in life expectancy at birth (e0) in 30 European countries from 1990 until 2014a by sex and region

Change in e0 1990–2014a (in years)
Observed Without smoking Without obesity Without alcohol Without smoking, obesity and alcohol
Men
Europe 4.98 3.48 5.54 5.29 4.24
Northern Europe 6.31 4.89 6.69 6.30 5.29
Western Europe 6.51 4.72 6.96 6.20 4.93
Southern Europe 6.59 5.22 6.96 5.94 5.09
Central Europe 7.52 5.51 8.04 7.54 6.06
Eastern Europe 1.20 –0.10 1.85 2.42 1.56
Women
Europe 3.96 4.10 4.15 4.03 4.32
Northern Europe 4.34 4.77 4.50 4.33 4.89
Western Europe 4.66 5.07 4.87 4.55 5.10
Southern Europe 5.03 5.28 5.16 4.78 5.14
Central Europe 6.01 6.68 6.11 6.03 6.71
Eastern Europe 1.87 1.63 2.04 2.24 2.14
a

For countries for which 2014 data were missing, we used data up until the latest available year: Bulgaria (2010), Greece (2013), Ukraine (2012) and Russia (2013).

Figure 3.

Figure 3

Trends in life expectancy at birth (e0), observed (= all-cause mortality) versus after excluding lifestyle-attributable mortality (= non-lifestyle-attributable mortality), 1990–2014*, by European region and sex. Lifestyle-attributable mortality refers to mortality that is attributable to smoking, obesity and alcohol combined. *For 2011 up to 2014, the weighted averages were calculated using the data for the latest available year: Bulgaria (2010), Greece (2013), Ukraine (2012) and Russia (2013).

Figure 1.

Figure 1

Trends over time in age-standardized smoking-, obesity- and alcohol-attributable mortality fractions (separately and combined) (%), ages 20–100 years, 1990–2014*, for the different European regions, by sex. Lifestyle refers to smoking, obesity and alcohol combined. *For 2011 up to 2014, the weighted averages were calculated using the data for the latest available year: Bulgaria (2010), Greece (2013), Ukraine (2012) and Russia (2013).

Table 1.

Impact of smoking, obesity and alcohol (separately and combined) on life expectancy at birth (e0) in 30 European countries, by sex and region, 1990 and 2014a by means of estimates of the potential gain in life expectancy (PGLE) (in years) from the elimination of mortality linked to the respective lifestyle factor. Lifestyle refers to smoking, obesity and alcohol combined

PGLE 1990 (in years)
PGLE 2014a (in years)
e0 1990 Lifestyle Smoking Obesity Alcohol e0 2014a Lifestyle Smoking Obesity Alcohol
Men
Europe 69.28 6.58 4.85 0.78 1.52 74.26 5.84 3.36 1.34 1.83
Northern Europe 73.11 4.06 2.83 0.66 0.84 79.42 3.04 1.40 1.03 0.83
Western Europe 72.51 5.51 3.98 0.72 1.27 79.02 3.94 2.19 1.18 0.96
Southern Europe 73.40 5.28 3.61 0.69 1.48 79.99 3.78 2.23 1.06 0.83
Central Europe 66.34 7.72 5.89 0.94 1.59 73.86 6.27 3.88 1.47 1.61
Eastern Europe 64.52 7.74 5.87 0.77 1.72 65.72 8.10 4.56 1.43 2.95
Women
Europe 77.28 1.94 0.62 0.99 0.38 81.23 2.30 0.77 1.18 0.45
Northern Europe 79.38 1.86 0.97 0.64 0.32 83.72 2.41 1.40 0.81 0.31
Western Europe 79.16 1.95 0.84 0.74 0.43 83.82 2.38 1.24 0.95 0.32
Southern Europe 80.08 1.47 0.27 0.79 0.45 85.10 1.59 0.52 0.92 0.20
Central Europe 75.07 2.10 0.86 1.03 0.28 81.08 2.81 1.53 1.14 0.31
Eastern Europe 74.57 2.04 0.47 1.27 0.35 76.44 2.31 0.23 1.44 0.72
a

For 2014, the weighted averages were calculated using the data for the latest available year for those countries for which 2014 data were missing: Bulgaria (2010), Greece (2013), Ukraine (2012) and Russia (2013).

Northern Europe: Denmark, Finland, Iceland, Norway, Sweden.

Western Europe: Austria, Belgium, Germany, France, Ireland, Luxembourg, Netherlands, Switzerland, the UK.

Southern Europe: Greece, Italy, Portugal, Spain.

Central Europe: Bulgaria, Czech Republic, Hungary, Poland, Slovakia, Slovenia.

Eastern Europe: Belarus, Estonia, Latvia, Lithuania, Ukraine, Russia.

Figure 2.

Figure 2

Trends over time in the potential gain in life expectancy (PGLE) after eliminating smoking-, obesity- and alcohol-attributable mortality (separately and combined), 1990–2014*, by European region and sex. Lifestyle-attributable mortality refers to mortality that is attributable to smoking, obesity and alcohol combined. *For 2011 up to 2014, the weighted averages were calculated using the data for the latest available year: Bulgaria (2010), Greece (2013), Ukraine (2012) and Russia (2013).

Across all 30 European countries in 2014, the age-standardized share of mortality due to smoking, obesity and alcohol combined (= lifestyle-attributable mortality fraction) was 38% among men and 19% among women. Among men, the LAMF mostly declined over the 1990–2014 period, albeit only recently in many Northern European and Central and Eastern European (CEE) countries (Figure 1 and Supplementary Figure 1, available as Supplementary data at IJE online). Among women, the LAMF generally increased over time. The declines in the LAMF for men were mostly driven by declines in smoking-attributable mortality, which started later in CEE. These declines in smoking-attributable mortality were, however, counterbalanced by increases in obesity-attributable mortality and, in Northern and CEE countries, as well by (decelerating) increases in alcohol-attributable mortality. The increases in the LAMF for women were driven by increases in smoking-attributable mortality, in obesity-attributable mortality and—particularly in CEE—in alcohol-attributable mortality.

The potential gain in life expectancy (PGLE) by eliminating lifestyle-attributable mortality declined from 6.6 to 5.8 years among men and increased from 1.9 to 2.3 years among women across the 30 European countries over the 1990–2014 period (Table 1 and Figure 2). Among men in Eastern Europe, the combined impact of smoking, obesity and alcohol on life expectancy was the greatest and was—in contrast to other regions—increasing up to 2005 primarily due to the increases in the PGLE for alcohol (Table 1 and Supplementary Table 1, available as Supplementary data at IJE online, Figure 2 and Supplementary Figure 2, available as Supplementary data at IJE online). Among women, the impact was the smallest and hardly changing in Southern Europe because moderate increases in PGLE for smoking and obesity were almost offset by small declines in PGLE for alcohol.

Between 1990 and 2014, e0 increased by 5.0 years among men across the 30 European countries (Table 2). Without lifestyle-attributable mortality, this increase would have been 4.2 years (i.e. 0.8 fewer years). The impact of lifestyle factors on life-expectancy trends was largest among men in Western, Southern and Central Europe, where the increase in e0 would have been about 1.5 years lower without lifestyle-attributable mortality (Table 2 and Supplementary Table 2, available as Supplementary data at IJE online). By contrast, among Eastern-European men, excluding lifestyle-attributable mortality would have resulted in a 0.4-year higher increase in e0. Among European women, the average increase in e0 from 1990 to 2014 was 4.0 years, whereas it would have been 4.3 years (i.e. 0.3 years higher) after excluding lifestyle-attributable mortality (Table 2). An increase in e0 after excluding lifestyle-attributable mortality can be observed for women in all European regions and countries (Table 2 and Supplementary Table 2, available as Supplementary data at IJE online). This impact of lifestyle factors on life-expectancy trends was biggest in Central Europe (difference of 0.7 years) and smallest in Southern Europe (difference of 0.1 years).

The trend in e0 after excluding lifestyle-attributable mortality was not only very similar for men and women across the 30 European countries (4.2 and 4.3 years, respectively); it was also more similar between countries and regions than all-cause mortality, at least for men (Figure 3). Among men, the variance between countries in e0 trends after excluding lifestyle-attributable mortality was 2.3, compared with 4.4 for all-cause mortality (Supplementary Table 2, available as Supplementary data at IJE online). Among women, the respective variances (2.0 vs 1.8) did not differ much. The increase in e0 was still far less favourable in Eastern Europe than in the other regions, even after excluding lifestyle-attributable mortality (Table 2). This seems mainly driven by the declines in e0 in the early 1990s (Figure 3). From around 2000, the increases in e0 were more similar between regions/countries.

Discussion

The combined impact of smoking, obesity and alcohol on e0 declined among men from 6.6 years in 1990 to 5.8 years in 2014, mainly due to declining smoking-attributable mortality. Among women, the combined impact increased from 1.9 to 2.3 years due to mortality increases in all three lifestyle-related factors. The observed increase in e0 over the 1990–2014 period was 5.0 years for men and 4.0 years for women. Without the combined effect of these three factors, the increase in e0 would have been 4.2–4.3 years for both men and women, and would have been more similar between countries for men.

To estimate mortality attributable to smoking, obesity and alcohol combined, we multiplicatively aggregated the risk-factor-specific mortality fractions, assuming that the risk factors are independent and uncorrelated.45 In case the effects of these three lifestyle risk factors were to overlap, rather than having synergistic relations, their joint contribution would be overestimated. It is unknown how the above-mentioned bias is changing over time and consequently how this would affect our results on the combined impact of the three lifestyle factors on trends in life expectancy.

The techniques employed to estimate smoking-, obesity- and alcohol-attributable mortality were selected based on a careful assessment of different estimation techniques48–50 and data availability. However, these techniques provide estimates only and should be interpreted as such.

Comparing our estimates of the PGLE from the elimination of smoking-, obesity- and alcohol-attributable mortality with those using the Global Burden of Diseases 2017 data44 revealed that our estimates in 2014 for men were, on average, 0.3 years lower for obesity in Eastern Europe and for alcohol across all regions, but ∼0.7 years higher for smoking in CEE; for women, they were, on average, largely similar for alcohol, but 0.3–0.4 years lower for obesity in CEE and for smoking in Southern and Eastern Europe (see Supplementary Table 3, available as Supplementary data at IJE online). Based on this comparison, our estimates seem generally conservative.

The differences in the impact of lifestyle on trends in e0 between men (accelerating the increase) and women (decelerating the increase) are mainly attributable to large sex differences in the onset of the smoking epidemic. Because men generally started smoking in large numbers 20–30 years earlier than women did, trends in smoking-attributable mortality had been declining for several decades for men, but were still increasing for women in most countries.15,16 This earlier onset of smoking among men can be attributed to the earlier uptake of risky health behaviours by men than by women.51 However, women’s behaviours followed those of men when their roles in society changed due to women’s emancipation and rising female labour-force participation.52 The more recent trends in obesity- and alcohol-attributable mortality have been largely similar for men and women, in line with their relatively similar prevalence trends.42,53

The observed differences between regions and countries in the impact of lifestyle factors on trends in e0 can also be linked to international differences in the progression of the smoking epidemic. For example, the large impact of lifestyle factors on trends among Central European women can be attributed to the later start and the greater impact of the smoking epidemic.16 Large international differences in alcohol-prevalence trends, however, have also played a role. Among men, the high levels and increasing trends in alcohol prevalence until around 2005 in Eastern Europe37 led to a deceleration, instead of an acceleration, of life-expectancy increases. In contrast, among women in Southern Europe, declines in alcohol prevalence54 contributed to the relatively small negative impact of lifestyle on life-expectancy trends. These differences can be mainly attributed to differences in drinking cultures (spirits in Eastern Europe, wine in Southern Europe) and in economic development (economic hardship in Eastern Europe).20

We observed that the e0 trends for non-lifestyle-attributable mortality ran parallel for men and women, and were more similar between countries than the observed e0 trends for men. Moreover, from a longer-term perspective, the e0 trends after excluding lifestyle-attributable mortality seem relatively stable over time (Supplementary Figure 3, available as Supplementary data at IJE online). This generally uniform trend may capture the underlying gradual long-term increase in life expectancy in Europe, which, as postulated in the epidemiological transition theory,55 reflects the long-term effects of socio-economic growth and medical progress. In European countries, large increases in gross domestic product per capita since the late nineteenth century56 drove the secular-mortality decline during the twentieth century. From the 1950s onwards, increases in life expectancy were achieved primarily through declines in adult cardiovascular mortality linked to medical improvements (hypertension treatments, statins, thrombolysis, stents).57

Although country differences in e0 trends can be largely explained by the three lifestyle factors studied, important country differences in e0 for non-lifestyle-attributable mortality remain. Particularly notable are the less favourable trends in Eastern Europe (i.e. former Soviet republics). The declines in e0 in the early 1990s may be attributable to the economic and political disruptions that followed the dissolution of the Soviet Union.21,58,59 However, from 2000 onwards, the e0 trends without lifestyle-attributable mortality were again more similar between countries. This convergence might reflect increasing similarities between countries in factors such as healthcare seeking, health-related policies and socio-cultural trends.

Smoking, obesity and alcohol likely contribute not only to country differences in e0 trends, but also to socio-economic differences in e0 trends. The three lifestyle factors contribute substantially to socio-economic differences in mortality60 due to higher current prevalence and associated mortality among people with low than with high SES.61 This contribution has increased over time, due to socio-economic differences in the uptake of new behaviours, and those with a higher socio-economic position generally being the first to change to healthier behaviours again.15,62,63

Because lifestyle factors have a large effect on life-expectancy trends, it is important to consider them when studying the stagnation in the increase in life expectancy. In Europe—particularly in the UK, but also in France, Germany, Sweden and the Netherlands—slowdowns in life-expectancy increases have been observed since 2011.24,25 Increases in both obesity prevalence25 and alcohol abuse among UK adults24 have been mentioned as potential causes. For women in France, Germany, Sweden and the Netherlands, rapid increases in smoking-attributable mortality (Supplementary Figure 1b, available as Supplementary data at IJE online)16 are likely contributors as well. Decomposing recent mortality trends into lifestyle-attributable mortality and remaining mortality may help to explain recent e0 trends.

Similarly, when predicting future trends in life expectancy, the time-varying impact of lifestyle factors should be considered. Because mortality forecasts mostly rely on the extrapolation of past age-specific mortality trends,64 a major challenge is to identify an underlying mortality trend that is sufficiently stable to serve as the basis for extrapolation.65,66 At the same time, such extrapolation should not ignore the factors that may cause deviations from this underlying trend.41,65,66 Our results indicate, first, that the past trends in non-lifestyle-attributable mortality serve as a better baseline for extrapolations than all-cause mortality; and, second, that smoking, obesity and alcohol are factors that seem to cause important deviations that should be predicted separately using more advanced techniques. Indeed, over the short term, less favourable e0 trends are expected because continued increases in smoking-attributable mortality for women in most countries and general increases in obesity-attributable mortality are anticipated. Increases in e0 are expected to become more favourable again once the declines in smoking-attributable mortality among women become more widespread and the hypothesized decline in obesity-attributable mortality17,18,28 eventually sets in.

Supplementary data

Supplementary data are available at IJE online.

Author contributions

F.J. conceived of the study. F.J. designed the study with input from S.T.L. and A.E.K. F.J. ran the first analyses. S.T.L. ran the final analyses. All authors interpreted the results. F.J. drafted the manuscript. A.E.K. provided critical input on the draft manuscript. F.J. revised the manuscript. All authors reviewed and approved the final version of the manuscript.

Funding

This work was supported by the Netherlands Organisation for Scientific Research (NWO) in relation to the research programme ‘Smoking, alcohol, and obesity, ingredients for improved and robust mortality projections’, under grant no. 452–13-001. See www.futuremortality.com.

Supplementary Material

dyaa273_Supplementary_Data

Acknowledgements

The authors thank Mark van der Broek (Research Master Economics, University of Groningen) for his help in running the analyses in R and making the initial tables and figures. Because the data we used consisted of data at the population level, available from data sets that exist in the public domain, ethical approval was not required. The data that were used as input for the tables and figures will be made available at the Open Science Framework: https://osf.io/j84c6/. The R code can be requested from the author.

Conflict of interest

None declared. The funding source had no role in the study design, collection, analysis or interpretation of the data; in the writing of the manuscript; or in the decision to submit the paper for publication.

References

  • 1.WHO. Global Status Report on Noncommunicable Diseases2014. Geneva: World Health Organization, 2014.
  • 2.WHO. Health in the European Union—Trends and Analysis. Copenhagen: World Health Organization—European Observatory on Health Systems and Policies, 2009. [Google Scholar]
  • 3.WHO. European Health Report 2018: More than Numbers—Evidence for All.  Geneva: World Health Organization—European Region, 2018.
  • 4. Preston SH, Glei DA, Wilmoth Jr.. Contribution of smoking to international differences in life expectancy. In: Crimmins EM, Preston SH, Cohen B (eds). International Differences in Mortality at Older Ages—Dimensions and Sources. Washington: The National Academies Press, 2010, pp. 105–31. [PubMed] [Google Scholar]
  • 5. Luy M, Wegner-Siegmundt C.. The impact of smoking on gender differences in life expectancy: more heterogeneous than often stated. Eur J Public Health 2015;25:706–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Renteria E, Jha P, Forman D, Soerjomataram I.. The impact of cigarette smoking on life expectancy between 1980 and 2010: a global perspective. Tob Control 2016;25:551–57. [DOI] [PubMed] [Google Scholar]
  • 7. Janssen F. The role of smoking in country differences in life expectancy across Europe. Nicotine Tob Res 2020. doi:10.1093/ntr/ntaa011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Zatonski W. Closing the Health Gap in the European Union. Warsaw: Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 2008. [Google Scholar]
  • 9. McCartney G, Mahmood L, Leyland AH, Batty GD, Hunt K.. Contribution of smoking-related and alcohol-related deaths to the gender gap in mortality: evidence from 30 European countries. Tob Control 2011;20:166–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Trias-Llimós S, Janssen F.. Alcohol and gender gaps in life expectancy in eight Central and Eastern European countries. Eur J Public Health 2018;28:687–92. [DOI] [PubMed] [Google Scholar]
  • 11. Olshansky SJ, Passaro DJ, Hershow RC. et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005;352:1138–45. [DOI] [PubMed] [Google Scholar]
  • 12. Preston SH, Stokes A.. Contribution of obesity to international differences in life expectancy. Am J Public Health 2011;101:2137–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Lhachimi SK, Nusselder WJ, Smit HA. et al. Potential health gains and health losses in eleven EU countries attainable through feasible prevalences of the life-style related risk factors alcohol, BMI, and smoking: a quantitative health impact assessment. BMC Public Health 2016;16:734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Östergren O, Martikainen P, Tarkiainen L, Elstad JI, Brønnum-Hansen H.. Contribution of smoking and alcohol consumption to income differences in life expectancy: evidence using Danish, Finnish, Norwegian and Swedish register data. J Epidemiol Commun H 2019;73:334–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Lopez AD, Collishaw NE, Piha T.. A descriptive model of the cigarette epidemic in developed countries. Tob Control 1994;3:242–47. [Google Scholar]
  • 16. Janssen F. Similarities and differences between sexes and countries in the mortality imprint of the smoking epidemic in 34 low-mortality countries, 1950-2014. Nicotine Tob Res 2020;22:1210–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Xu L, Lam TH.. Stage of obesity epidemic model: Learning from tobacco control and advocacy for a framework convention on obesity control. J Diabetes 2018;10:564–71. [DOI] [PubMed] [Google Scholar]
  • 18. Jaacks LM, Vandevijvere S, Pan A. et al. The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol 2019;7:231–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Shield K, Manthey J, Rylett M. et al. National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study. Lancet Public Health 2020;5:e51–61. [DOI] [PubMed] [Google Scholar]
  • 20. Janssen F, El Gewily S, Bardoutsos A, Trias-Llimós S.. Past and future alcohol-attributable mortality in Europe. Int J Environ Res Public Health 2020;17:9024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Vallin J, Meslé F.. Convergences and divergences in mortality: a new approach to health transition. Demogr Res 2004;2:11–44. [Google Scholar]
  • 22. Rostron BL, Wilmoth JR.. Estimating the effect of smoking on slowdowns in mortality declines in developed countries. Demography 2011;48:461–79. [DOI] [PubMed] [Google Scholar]
  • 23. Lindahl-Jacobsen R, Oeppen J, Rizzi S. et al. Why did Danish women's life expectancy stagnate? The influence of interwar generations' smoking behaviour. Eur J Epidemiol 2016;31:1207–11. [DOI] [PubMed] [Google Scholar]
  • 24. Leon DA, Jdanov DA, Shkolnikov VM.. Trends in life expectancy and age-specific mortality in England and Wales, 1970-2016, in comparison with a set of 22 high-income countries: an analysis of vital statistics data. Lancet Public Health 2019;4:e575-82–e582. [DOI] [PubMed] [Google Scholar]
  • 25. Raleigh V. Trends in Life Expectancy in EU and Other OECD Countries: Why Are Improvements Slowing? OECD Health Working Papers 2019/108. Paris: Organisation for Economic Co-operation and Development, 2019.
  • 26.WHO. The Challenge of Obesity in the WHO European Region and the Strategies for Response: Summary. Copenhagen: World Health Organization, 2007.
  • 27. Vidra N, Trias-Llimós S, Janssen F.. Impact of obesity on life expectancy among different European countries: secondary analysis of population-level data over the 1975-2012 period. BMJ Open 2019;9:e028086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Janssen F, Bardoutsos A, Vidra N.. Obesity prevalence in the long-term future in 18 European countries and in the USA. Obes Facts 2020;13:514–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Rehm J, Sulkowska U, Manczuk M. et al. Alcohol accounts for a high proportion of premature mortality in central and eastern Europe. Int J Epidemiol 2007;36:458–67. [DOI] [PubMed] [Google Scholar]
  • 30. Trias-Llimós S, Kunst AE, Jasilionis D, Janssen F.. The contribution of alcohol to the East-West life expectancy gap in Europe from 1990 onward. Int J Epidemiol 2018;47:731–39. [DOI] [PubMed] [Google Scholar]
  • 31. Stanaway JD, Afshin A, Gakidou E. et al. 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1923–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Reitsma MB, Fullman N, Ng M. et al. A systematic analysis from the global burden of disease study 2015. Lancet 2017;389:1885–906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.GBD 2015 Obesity Collaborators; Afshin A, Forouzanfar MH.. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017;377:13–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study. Lancet 2018;392:1015–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Janssen F, Rousson V, Paccaud F.. The role of smoking in changes in the survival curve: an empirical study in 10 European countries. Ann Epidemiol 2015;25:243–49. [DOI] [PubMed] [Google Scholar]
  • 36. Martikainen P, Mäkelä P, Peltonen R, Myrskylä M.. Income differences in life expectancy: the changing contribution of harmful consumption of alcohol and smoking. Epidemiology 2014;25:182–90. [DOI] [PubMed] [Google Scholar]
  • 37. Jasilionis D, Meslé F, Shkolnikov VM, Vallin J.. Recent life expectancy divergence in Baltic countries. Eur J Population 2011;27:403–31. [Google Scholar]
  • 38. Janssen F, van der Broek M, Bardoutsos A, Vidra N.. Obesity-attributable Mortality in the Long-term Future in Europe. NIDI Working Paper 2020/06. The Hague: Netherlands Interdisciplinary Demographic Institute, 2020.
  • 39.Human Mortality Database. University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). www.mortality.org (27 August 2018, date last accessed).
  • 40. Peto R, Boreham J, Lopez AD, Thun M, Heath C.. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992;339:1268–78. [DOI] [PubMed] [Google Scholar]
  • 41. Janssen F, van Wissen L, Kunst AE.. Including the smoking epidemic in internationally coherent mortality projections. Demography 2013;50:1341–62. [DOI] [PubMed] [Google Scholar]
  • 42.NCD, Risk Factor C; (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 2017;390:2627–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.DYNAMO-HIA Consortium. Workpackage 7: Overweight and Obesity: Report on Data Collection for Overweight and Obesity Prevalence and Related Relative Risks. London: International Association for the Study of Obesity, 2010.
  • 44.Global Burden of Disease Study 2017. GBD Results Tool. Seattle, WA: Institute for Health Metrics and Evaluation (IHME), 2019. https://gbd2017.healthdata.org/gbd-search/ (6 April 2018, date last accessed).
  • 45. Ezzati M, Vander Hoorn S, Rodgers A, Lopez AD, Mathers CD, Murray CJ.. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003;362:271–80. [DOI] [PubMed] [Google Scholar]
  • 46. Lim SS, Carnahan E, Nelson EC. et al. Validation of a new predictive risk model: measuring the impact of the major modifiable risks of death for patients and populations. Popul Health Metr 2015;13:27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Tsai SP, Lee ES, Hardy RJ.. The effects of a reduction in leading causes of death: potential gains in life expectancy. Am J Public Health 1978;68:966–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Vidra N, Bijlsma M, Janssen F.. Impact of different estimation methods on obesity-attributable mortality levels and trends: the case of the Netherlands. Int J Environ Res Public Health 2018;15:2146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Trias-Llimós S, Martikainen P, Mäkelä P, Janssen F.. F. Comparison of different approaches for estimating age-specific alcohol-attributable mortality: the cases of France and Finland. PLoS One 2018;13:e0194478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Stoeldraijer L, Bonneux L, van Duin C, van Wissen L, Janssen F.. The future of smoking‐attributable mortality: the case of England & Wales, Denmark and the Netherlands. Addiction 2015;110:336–45. [DOI] [PubMed] [Google Scholar]
  • 51. Rogers R, Everett BG, Saint Onge JM, Krueger PM.. Social, behavioral, and biological factors, and sex differences in mortality. Demography 2010;47:555–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Waldron I. Trends in gender differences in mortality: relationships to changing gender differences in behaviour and other causal factors. In: Annandale E, Hunt K (eds). Gender Inequalities in Health. Buckingham: Open University Press, 2000, pp. 150–81. [Google Scholar]
  • 53.WHO. Global Status Report on Alcohol and Health 2018. Geneva: World Health Organization, 2019. [Google Scholar]
  • 54. Gual A, Colom JOAN.. Why has alcohol consumption declined in countries of southern Europe? Addiction 1997;92:S21–31. [PubMed] [Google Scholar]
  • 55. Omran AR. The epidemiologic transition theory revisited thirty years later. World Health Statistics Quarterly 1998;52:99–119. [Google Scholar]
  • 56. Janssen F, Kunst AE, Mackenbach JP.. Association between gross domestic product throughout the life course and old-age mortality across birth cohorts: parallel analyses of seven European countries, 1950-1999. Soc Sci Med 2006;63:239–54. [DOI] [PubMed] [Google Scholar]
  • 57. Mensah GA, Wei GS, Sorlie PD. et al. Decline in cardiovascular mortality: possible causes and implications. Circ Res 2017;120:366–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Leon DA. Trends in European life expectancy: a salutary view. Int J Epidemiol 2011;40:271–77. [DOI] [PubMed] [Google Scholar]
  • 59. McKee M, Shkolnikov V.. Understanding the toll of premature death among men in eastern Europe. BMJ 2001;323:1051–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Petrovic D, de Mestral C, Bochud M. et al. The contribution of health behaviors to socioeconomic inequalities in health: a systematic review. Prev Med 2018;113:15–31. [DOI] [PubMed] [Google Scholar]
  • 61. Mackenbach JP. Health Inequalities in Europe: New Insights from Comparative Studies. Rotterdam: Erasmus University Publishing, 2016. [Google Scholar]
  • 62. Sobal J, Stunkard AJ.. Socioeconomic status and obesity: a review of the literature. Psychol Bull 1989;105:260–75. [DOI] [PubMed] [Google Scholar]
  • 63. Mackenbach JP. The persistence of health inequalities in modern welfare states: the explanation of a paradox. Soc Sci Med 2012;75:761–69. [DOI] [PubMed] [Google Scholar]
  • 64. Stoeldraijer L, van Duin C, van Wissen L, Janssen F.. Impact of different mortality forecasting methods and explicit assumptions on projected future life expectancy: the case of the Netherlands. Demogr Res 2013;29:323–54. [Google Scholar]
  • 65. Janssen F. Advances in mortality forecasting: introduction. Genus 2018;74:21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Janssen F, Kunst A.. The choice among past trends as a basis for the prediction of future trends in old-age mortality. Pop Stud 2007;61:315–26. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

dyaa273_Supplementary_Data

Articles from International Journal of Epidemiology are provided here courtesy of Oxford University Press

RESOURCES